Vertiseit - Accelerating Momentum
2022-03-03 09:45:00
Redeye retains its Base Case for Vertiseit following a Q4 report beating our forecasts regarding both sales and EBIT. Dise had a superb quarter with strong growth and improving SaaS metrics. We leave our forecasts largely unchanged.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/